Found: 139
Select item for more details and to access through your institution.
Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 2, p. 343, doi. 10.1007/s00432-017-2540-1
- By:
- Publication type:
- Article
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 12, p. 2047, doi. 10.1007/s00432-013-1518-x
- By:
- Publication type:
- Article
Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 10, p. 1681, doi. 10.1007/s00432-013-1490-5
- By:
- Publication type:
- Article
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades.
- Published in:
- Archives of Gynecology & Obstetrics, 2013, v. 288, n. 6, p. 1203, doi. 10.1007/s00404-013-3069-4
- By:
- Publication type:
- Article
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2860, doi. 10.3390/ijms24032860
- By:
- Publication type:
- Article
Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1615, doi. 10.3390/ijms17101615
- By:
- Publication type:
- Article
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 15, doi. 10.1007/s10549-021-06319-z
- By:
- Publication type:
- Article
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 3, p. 557, doi. 10.1007/s10549-018-05112-9
- By:
- Publication type:
- Article
Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 4, p. 1118, doi. 10.1245/s10434-014-4122-7
- By:
- Publication type:
- Article
Surgical Outcome after Neoadjuvant Chemotherapy and Bevacizumab: Results from the GeparQuinto Study (GBG 44).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 8, p. 2517, doi. 10.1245/s10434-014-3606-9
- By:
- Publication type:
- Article
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2006, v. 13, n. 12, p. 1702, doi. 10.1245/s10434-006-9058-0
- By:
- Publication type:
- Article
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 3, p. 689, doi. 10.4143/crt.2019.497
- By:
- Publication type:
- Article
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01619-2
- By:
- Publication type:
- Article
Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0079775
- By:
- Publication type:
- Article
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0045826
- By:
- Publication type:
- Article
Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 341, doi. 10.1007/s00281-011-0261-0
- By:
- Publication type:
- Article
Neoadjuvant Clinical Trials for the Treatment of Primary Breast Cancer: The Experience of the German Study Groups.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 1, p. 27, doi. 10.1007/s11912-011-0212-x
- By:
- Publication type:
- Article
What Is the Current Standard of Care for Anti-HER2 Neoadjuvant Therapy in Breast Cancer?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 20
- By:
- Publication type:
- Article
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00439-5
- By:
- Publication type:
- Article
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0156-0
- By:
- Publication type:
- Article
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0155-1
- By:
- Publication type:
- Article
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0026-6
- By:
- Publication type:
- Article
Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase Ill Randomized GeparTrio Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 8, p. 552, doi. 10.1093/jnci/djn089
- By:
- Publication type:
- Article
Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 10, p. 563, doi. 10.1159/000367643
- By:
- Publication type:
- Article
Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
- Published in:
- Oncogene, 2002, v. 21, n. 20, p. 3162
- By:
- Publication type:
- Article
Shifting the Paradigm: The Transformative Role of Neoadjuvant Therapy in Early Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 18, p. 3236, doi. 10.3390/cancers16183236
- By:
- Publication type:
- Article
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1580, doi. 10.3390/cancers15051580
- By:
- Publication type:
- Article
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 844, doi. 10.3390/cancers13040844
- By:
- Publication type:
- Article
Avoiding Axillary Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3698, doi. 10.3390/cancers12123698
- By:
- Publication type:
- Article
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2787, doi. 10.3390/cancers12102787
- By:
- Publication type:
- Article
Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1186, doi. 10.3390/cancers11081186
- By:
- Publication type:
- Article
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 59, doi. 10.1007/s10549-017-4480-5
- By:
- Publication type:
- Article
Efficacy and safety of nab-paclitaxel 125 mg/m and nab-paclitaxel 150 mg/m compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 495, doi. 10.1007/s10549-017-4200-1
- By:
- Publication type:
- Article
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 377, doi. 10.1007/s10549-015-3479-z
- By:
- Publication type:
- Article
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 141, doi. 10.1007/s10549-014-3217-y
- By:
- Publication type:
- Article
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 1, p. 61, doi. 10.1007/s10549-014-3079-3
- By:
- Publication type:
- Article
RANK expression as a prognostic and predictive marker in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 2, p. 307, doi. 10.1007/s10549-014-2955-1
- By:
- Publication type:
- Article
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 1, p. 153, doi. 10.1007/s10549-014-2861-6
- By:
- Publication type:
- Article
Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 3, p. 779, doi. 10.1007/s10549-013-2589-8
- By:
- Publication type:
- Article
Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
- Published in:
- 2012
- By:
- Publication type:
- Report
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer-results from the GeparQuattro study (GBG 40).
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 3, p. 863, doi. 10.1007/s10549-011-1621-0
- By:
- Publication type:
- Article
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 130, n. 2, p. 477, doi. 10.1007/s10549-011-1715-8
- By:
- Publication type:
- Article
Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 125, n. 1, p. 145, doi. 10.1007/s10549-010-1228-x
- By:
- Publication type:
- Article
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 124, n. 1, p. 133, doi. 10.1007/s10549-010-1103-9
- By:
- Publication type:
- Article